Mallinckrodt plc Files Proxy Statement
| Field | Detail |
|---|---|
| Company | Mallinckrodt PLC |
| Form Type | DEFA14A |
| Filed Date | Sep 30, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance
TL;DR
Mallinckrodt plc filed its proxy statement on 9/30/25. Shareholders, pay attention to voting items.
AI Summary
Mallinckrodt plc filed a DEFA14A on September 30, 2025, detailing proxy statement information. The filing, with accession number 0001104659-25-095057, pertains to the company's corporate governance and shareholder matters. Mallinckrodt plc is incorporated in L2 and its fiscal year ends on December 26.
Why It Matters
This filing provides shareholders with crucial information regarding voting matters and corporate decisions, enabling them to participate in the company's governance.
Risk Assessment
Risk Level: low — This is a routine proxy filing (DEFA14A) and does not contain new financial performance data or significant strategic changes.
Key Players & Entities
- Mallinckrodt plc (company) — Registrant
- 0001104659-25-095057 (filing_id) — Accession Number
- September 30, 2025 (date) — Filing Date
- L2 (jurisdiction) — State of Incorporation
- December 26 (date) — Fiscal Year End
FAQ
What is the purpose of a DEFA14A filing?
A DEFA14A filing is a Schedule 14A Proxy Statement filed with the SEC, used by companies to solicit proxy votes from shareholders for annual or special meetings.
When was this specific DEFA14A filing made by Mallinckrodt plc?
This DEFA14A filing by Mallinckrodt plc was made on September 30, 2025.
What is the accession number for this filing?
The accession number for this filing is 0001104659-25-095057.
Where is Mallinckrodt plc incorporated and when does its fiscal year end?
Mallinckrodt plc is incorporated in L2 and its fiscal year ends on December 26.
What is the SIC code for Mallinckrodt plc?
The Standard Industrial Classification (SIC) code for Mallinckrodt plc is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 692 words · 3 min read · ~2 pages · Grade level 12 · Accepted 2025-09-30 16:30:27
Filing Documents
- tm2527613d1_defa14a.htm (DEFA14A) — 24KB
- tm2527613d1_def14aimg001.jpg (GRAPHIC) — 21KB
- tm2527613d1_def14aimg002.jpg (GRAPHIC) — 6KB
- 0001104659-25-095057.txt ( ) — 62KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Definitive Additional Materials Soliciting Material under §240.14a-12 Mallinckrodt public limited company (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. September 30, 2025 Dear Shareholder: We have recently sent you proxy materials for the upcoming Extraordinary General Meeting of Shareholders of Mallinckrodt plc which will be held on October 8, 2025. We are contacting you to alert you to two important actions : 1. Vote Your Mallinckrodt Shares Now. Our Board of Directors unanimously recommends that you vote FOR all the resolutions on the agenda. Your vote is important , no matter how many or how few shares you may own. PLEASE VOTE TODAY! Go to www.proxyvote.com and enter your 16-digit control number If you have any questions about, or need assistance with, voting your shares, please call our proxy solicitor: INNISFREE M&A INCORPORATED TOLL-FREE, at 888-750-9498 (from the U.S. and Canada) Or at +1 (412) 232-3651 (from other countries) 2. Verify your accounts; ensure you understand benefits and entitlements of your holdings in Mallinckrodt shares; record any transfers now! As announced earlier this year, Mallinckrodt intends to effect a spin-off of Par Health, its combined generics and sterile injectables business, into an independent company, subject to the approval of the Mallinckrodt Board of Directors and the satisfaction of certain other conditions (the “ Potential Spin-off ”). We remind shareholders that under the Irish law, registration in Mallinckrodt’s share register (maintained by Computershare US) is determinative of membership in Mallinckrodt . This includes any potential benefits or entitlements in connection with the Potential Spin-off. The following summarizes helpful considerations for your Mallinckrodt holdings in connection with the Potential Spin-off: ü If you have not received your statement noting your Mallinckrodt holdings, or have not accessed your account online, do so now . If you are a record owner, contact Computershare as indicated below. Otherwise, contact your broker or a bank. ü If you hold beneficially (e.g., through a broker, bank or other intermediary), you are not considered the holder of record of such shares. This means that your broker or bank – not you – is registered on Mallinckrodt’s share register, and your benefits and entitlements in respect of your Mallinckrodt shares would be dependent on such intermediaries. Because Mallinckrodt is an Irish, privately held company, there are potential administrative complexities with holding your shares through an intermediary, and neither the Company nor Computershare will be able to verify your holdings. If you wish to have your holdings recorded on Mallinckrodt’s share register, you should reach out to your brokers and instruct the transfer as soon as possible. ü If you have executed trades in Mallinckrodt shares that have not been registered on Mallinckrodt’s share register , register the transfers as soon as possible. We remind shareholders that the process of registering any trades and paying applicable stamp duty is described on Mallinckrodt’s investor relations website at https://ir.mallinckrodt.com. Help is here: If your shares are held in Computershare, for support with your account, please contact: Computershare US Toll free: 1-866-644-4127 Outside US & Canada: 1-781-575-2906 For support with share transfers, please contact: Georgeson (Mallinckrodt’s information agent): Toll Free: (866) 585-7241 Outside the US: (310) 853-6676 By email: MallExchange@Georgeson.com For support with voting your shares, please contact: Innisfree M&A Incorporated Toll Free: 888-750-9498 Outside US and Canada: (412) 232-3651 For other inquiries, please contact: Mallinckrodt’s Corporate Secretary’s Office at corporate.secretary@mnk.com Thank you for your attention to these matters, and please feel free to reach out with any questions. Sincerely, Mark Tyndall EVP, Chief Legal Officer & Corporate Secretary